期刊文献+

单纯疱疹病毒Ⅰ型糖蛋白B核酸疫苗安全性的初步评价 被引量:1

Initial evaluation on safety of herpes simplex virus Ⅰglycoprotein B DNA vaccine in mice
下载PDF
导出
摘要 目的:通过检测免疫小鼠的血液生理学、血液生化学指标,以及8个重要组织器官的病理学,初步评估单纯疱疹病毒Ⅰ型糖蛋白B核酸疫苗(pcDNA3-gB)的安全性。方法:将24只昆明种小鼠随机分为对照组、100、300和500mg.L-1组,每组6只。各组分别于小鼠股四头肌肌肉注射1mL生理盐水、100、300和500mg.L-1pcDNA3-gB。末次免疫10d后,进行血液生理学、血液生化学、肝、肾、心、脑、脾、角膜、视网膜、三叉神经节的病理学检查。结果:各组小鼠均存活,且血红细胞计数(RBC)、血红蛋白浓度(HB)、红细胞压积(HCT)、红细胞平均体积(MCV)、红细胞平均血红蛋白(MCH)、红细胞平均血红蛋白浓度(MCHC)、血小板记数(PLT)、白细胞计数(WBC)、红细胞体积分布宽度(RDW)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、碱性磷酯酶(ALP)、总胆红素(T-BIL)、尿素(BUN)、肌肝(Cr)、总蛋白(TP)、白蛋白(ALB)、血糖(GLU)及组织病理学与对照组比较差异均无显著性(P>0.05)。结论:不同剂量pcDNA3-gB免疫小鼠后,对小鼠的生命、血液生理学、血液生化学、组织病理学指标均无明显影响,初步说明pcDNA3-gB是安全的。 Objective To evaluate the safety of herpes simplex virus Ⅰ glycoprotein B DNA vaccine (pcDNA3-gB) in mice by examing the indexes of hematology, hematological biochemistry and pathological results of eight important organs of immunized mice. Methods Twenty-four mice were divided into four groups (n=6) randomly, including control group, 100, 300 and 500 mg·L^-1 pcDNA3 gB groups, and 1 mL sodium chloride, 100, 300 and 500 mg·L^-1 pcDNA3-gB were injected into mice through the quadriceps in various groups. At the 10th day after last immunity, the blood samples were collected and the indexes of hematology, hematology biochemistry and the pathological results of liver, kidney, heart, brain, spleen, cornea, retina and trigeminal ganglia were examined. Results The differencesinRBC, HB, HCT, MCV, MCH, MCHC, PLT, RDW, WBC, ALT, AST, ALP, T-BIL, GLU, ALB, TP, Cr, BUN betwen control group and pcDNA3-gB groups were not significant as well as the pathological results of liver, heart, kidney, brain, spleen, cornea, retina and trigeminal ganglion (P〉0.05). Conclusion pcDNA3-gB with different doses have not significant effect on the indexes of hematology,hematological biochemistry and pathology in immunized mice. It is initially proved that pcDNA3-gB is safe.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2008年第5期806-809,共4页 Journal of Jilin University:Medicine Edition
基金 吉林省科技厅科技发展计划项目资助课题(200505181) 长春市科技发展计划项目资助课题(03-171S10) 吉林大学新技术新疗法资助课题(200104)
关键词 疱疹病毒1型 糖蛋白B 核酸疫苗 安全性 小鼠 herpes virus 1, human glycoprotein B DNA vaccine safety mice
  • 相关文献

参考文献11

  • 1Ghiasi H, Kaiwar R, Nesburn AB, et al. Expression of seven herpes simplexvirus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gl): comparative protection against lethal challenge in mice[J]. J Virol , 1994, 68 (4): 2118-2126.
  • 2Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo[J]. Science, 1990, 247 (3): 1465- 1468.
  • 3Shroff KE, Smith LR, Baine Y, et al. Potential for plasmid DNAs as vaccines for the new millennium [J]. Pharms SciTechnol Today, 1999, 2 (5) : 205-212.
  • 4Kosovsky J, Vojvodova A, Oravcova I, et al. Herpes simplex virus 1 (HSV -1 ) strain HSZP glycoprotein B gene: comparison of mutation among strains differing in virulence[J].Virus Genes, 2000, 20 (1) : 27-33.
  • 5Abol GB, Vladimir N. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunization with heropes simlex virus type-1 genes specifying glycoproteins gB and gD [J]. J Med Microbiol, 2002, 51 (1): 350-357.
  • 6孟祥俊,贺冰,冯非,李光源,毕军.单纯疱疹病毒1型糖蛋白B基因疫苗的构建[J].吉林大学学报(医学版),2004,30(5):717-720. 被引量:9
  • 7李光源,贺冰,冯非,孟祥俊,宋忆淑,王晓祺.单纯疱疹病毒Ⅰ型糖蛋白B基因疫苗的构建及细胞免疫学研究[J].中国免疫学杂志,2005,21(7):535-539. 被引量:3
  • 8葛金玲,贺冰,袁静,孟祥俊,许海涛.IL-18基因佐剂协同HSV-1 gB DNA疫苗免疫诱导的特异性免疫应答[J].中国免疫学杂志,2007,23(4):317-319. 被引量:6
  • 9J.萨姆布鲁克,E.F.弗里奇,T.曼尼阿蒂斯.分子克隆试验指南[M].第2版.北京:科学出版社,1996:16-323.
  • 10邓普辉.动物细胞病理学[M].北京:中国农业出版社,1995.94.

二级参考文献28

  • 1王晓祺,谭岩,段秀梅,刘玲丽,方艳秋,姜艳芳,许淑芬,刘力华.流式细胞术检测细胞毒方法的建立[J].中国免疫学杂志,2004,20(10):704-707. 被引量:14
  • 2孟祥俊,贺冰,冯非,李光源,毕军.单纯疱疹病毒1型糖蛋白B基因疫苗的构建[J].吉林大学学报(医学版),2004,30(5):717-720. 被引量:9
  • 3刘晓娟,朱明昭,宋国兴,许于飞,刘宏伟,王盛,杨宝玲,董方田,许雪梅.白介素2基因佐剂协同单纯疱疹病毒1型糖蛋白D核酸疫苗免疫诱导的特异性免疫应答[J].中国医学科学院学报,2005,27(1):67-72. 被引量:11
  • 4[2]萨姆布鲁克 J,弗里奇 EF,曼尼阿蒂斯 T.分子克隆试验指南[M].第2版.北京:科学出版社,1996:16-323.
  • 5[3]Kosovsky, Vojvodova A, Oravcova I,et al. Herpes simplex virus 1 (HSV-1) strain HSZP glycoprotein B gene: comparison of mutation among strains differing in virulence[J]. Virus Genes, 2000,20(1):27-33.
  • 6[5]Caselli E, Balboni PG, Incorvaia C,et al. Local and systemic inoculation of DNA or protein gpB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection[J].Vaccine, 2001,19:1225-1231.
  • 7[6]Abolghasem B, Vladimir N. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunization with herpes simlex virus type-1 genes specifying glycoproteins gpB and gD[J]. J Med Microbiol, 2002,51(1): 350-357.
  • 8[7]Nass PH,Elkins KL, Weir JP, et al. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection[J]. Vaccine, 2001,19:1538-1546.
  • 9Ghiasi H,Bahri S,Nesburn A B et al.Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins [J].Invest Ophthalmol Vis Sci,1995;36(7):1352.
  • 10Baghian A,Chouljenko V N,Dauvergne O et al.Protective immunity against lethal HSV-Ⅰ challenge in mice by nucleic acid-based immunization with heropes simlex virus type-1 genes specifying glycoproteins gB and gD [J].J Med Microbiol,2002;51(4):350.

共引文献26

同被引文献14

  • 1杨慧兰,周翠,关蕾,赵举峰,樊建勇.单纯疱疹病毒II型CTL表位DNA疫苗的Th1/Th2免疫应答研究[J].中国皮肤性病学杂志,2007,21(7):402-404. 被引量:5
  • 2Cooper D,Mester JC,Guo M,et al.Epitope mapping of full-length glyco-protein D from HSV-2 reveals a novel CD4+CTL epitope located at the transmembrane-cytoplasmic junction(J).Cell Immunol,2006;239(2):113-20.
  • 3Haynes JR,Arrington I,Dong L,et al.Potent protective cellular immune responses generated by a DNA vaccine ending HSV-2 ICP27 and E.coli heat labile enterotoxin(J).Vaccine,2006;24(23):5016-26.
  • 4Sin JI,Kim JJ,Boyer JD,et al.In vivo modulation of vaccine-induced im-mune responses toward a 7 h phenotype micreasea potency and vaccine effectiveness in a herpes simplex virus type 2 mouse model(J).J Virol,1999;73(1):501-9.
  • 5Van Hall T,Laban S,Koppers-Lalic D,et al.The varicellovirus-encoded TAP inhibitor UL 49.5 regulates the presentation of CTL epitopes by Qa-lb(lJ).J Immunol,2007;178(2):657-62.
  • 6Wang LF,YU M.Epitope indentification and discovery using phage dis-play libraries:application invaccine development and diagnostics(J).Curr Drug Targets,2004;5(1):1215-9.
  • 7Domingo C,Gadea I,Pardeiro M,et al.Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D(J).Vaccine,2003;21(25-26):3565-94.
  • 8Bernstein DI.Effect of vaccination with vaccinaia virus expressing HSV-2 glycoprotein D on protection from genital HSV-2 infection(J).Vac-cine,2000;18:1351-8.
  • 9Jazayeri M,Soleimanjahi H,Fotouhi F,et al.Comparison of intramuscu-lar and footpad subcutaneous immunization with DNA vaccine encoding HSV-gD2 in mice(J).Comp Immu Microbiol Infect Dis,2009;32(5):453-61.
  • 10Fotouhi F,Soleimanjahi H,Roostaee MH,et al.Enhancement of protec-tive humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting(J).FEMS Immu Med Mi-crobiol,2008;54(1):18-26.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部